Stock Events

Stock Events

Tego Science 

₩6,710
2
-₩240-3.45% 06:30 Today

Statistics

Day High
7,030
Day Low
6,450
52W High
18,500
52W Low
5,230
Volume
2,679
Avg. Volume
4,550
Mkt Cap
54.41B
P/E Ratio
-
Dividend Yield
-
Dividend
-

Dividends

0%Dividend Yield
Apr 2015
₩50
10Y Growth
N/A
5Y Growth
N/A
3Y Growth
N/A
1Y Growth
N/A

Earnings

Dec 31Expected
Q1 2017
Q2 2017
Q3 2017
Q4 2017
Q1 2018
Q2 2018
Q3 2018
-540
-343
-146
50
Expected EPS
N/A
Actual EPS
-319

Financials

-118.04%Profit Margin
Unprofitable
2020
2021
2022
2023
2024
2025
5.94BRevenue
-7.01BNet Income

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Regeneron Pharmaceuticals
REGN
Mkt Cap95.99B
Regeneron Pharmaceuticals, Inc. focuses on regenerative medicine and biotechnology, similar to Tego Science's work in cell therapy and skin regeneration.
Vertex Pharmaceuticals
VRTX
Mkt Cap141.65B
Vertex Pharmaceuticals Incorporated engages in developing therapies for treating cystic fibrosis and other diseases, competing in the biotech sector like Tego Science.
Biomarin Pharmaceutical
BMRN
Mkt Cap11.33B
BioMarin Pharmaceutical Inc. specializes in enzyme replacement therapies, which overlaps with Tego Science's focus on innovative biological treatments.
Incyte
INCY
Mkt Cap24.54B
Incyte Corporation works on novel therapeutics, including for dermatology, which is directly competitive with Tego Science's dermatological applications.
CRISPR Therapeutics
CRSP
Mkt Cap4.97B
CRISPR Therapeutics AG is a leader in gene editing, a cutting-edge technology that competes with Tego Science's advanced therapeutic methodologies.
Intellia Therapeutics
NTLA
Mkt Cap1.75B
Intellia Therapeutics, Inc. is involved in CRISPR/Cas9 technology, competing with Tego Science in the field of advanced genetic engineering and therapy.

About

TegoScience Inc. produces and sells wound-healing skin cell therapy products from human epithelial cells in South Korea. The company's products include Holoderm, Kaloderm, and Rosmir. It also provides Neoderm, contract research, and Skinbank services. The company was founded in 2001 and is based in Seoul, South Korea.
Show More
CEO
Dr. Saewha Jeon Ph.D.
Country
South Korea
ISIN
KR7191420009

Listings

KQ
KR
191420.KQ

0 Comments

Share your thoughts

FAQs

What is Tego Science stock price today?▼
The current price of 191420.KQ is ₩6,710 KRW — it has decreased by -3.45% in the past 24 hours. Watch Tego Science stock price performance more closely on the chart.
What is Tego Science stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on KOSDAQ exchange Tego Science stocks are traded under the ticker 191420.KQ.
Is Tego Science stock price growing?▼
191420.KQ stock has fallen by -9.32% compared to the previous week, the month change is a -6.28% fall, over the last year Tego Science has showed a -61.21% decrease.
What is Tego Science market cap?▼
Today Tego Science has the market capitalization of 54.41B
What were Tego Science earnings last quarter?▼
191420.KQ earnings for the last quarter are -319 KRW per share, whereas the estimation was N/A KRW resulting in a N/A surprise. The estimated earnings for the next quarter are N/A KRW per share.
What is Tego Science revenue for the last year?▼
Tego Science revenue for the last year amounts to 5.94B KRW.
What is Tego Science net income for the last year?▼
191420.KQ net income for the last year is -7.01B KRW.
Does Tego Science pay dividends?▼
Yes, 191420.KQ dividends are paid annual. The last dividend per share was 50 . As of today, Dividend Yield (FWD)% is 0%.
In which sector is Tego Science located?▼
Tego Science operates in the Health & Wellness sector.
When did Tego Science complete a stock split?▼
The last stock split for Tego Science was on July 11, 2018 with a ratio of 1:1.
Where is Tego Science headquartered?▼
Tego Science is headquartered in Seoul, South Korea.